ON THE ASSESSMENT AND TREATMENT OF PATIENTS WITH CHRONIC PROSTATITIS IN PERSISTENT UROGENITAL CHLAMYDIOSIS

Background: Urogenital chlamydial infection is the most prevalent among sexually transmitted disorders that is associated with high rates of complications (chronic prostatitis, salpingoophoritis, etc.) and adverse outcomes, such as sexual and reproductive dysfunction. In the last years, the frequenc...

Full description

Bibliographic Details
Main Authors: V. A. Molochkov, V. A. Aleshkin, T. A. Skirda, A. V. Karaulov, Yu. V. Molochkova, E. V. Antonova
Format: Article
Language:Russian
Published: MONIKI 2016-06-01
Series:Alʹmanah Kliničeskoj Mediciny
Subjects:
Online Access:https://www.almclinmed.ru/jour/article/view/316
_version_ 1831549225152806912
author V. A. Molochkov
V. A. Aleshkin
T. A. Skirda
A. V. Karaulov
Yu. V. Molochkova
E. V. Antonova
author_facet V. A. Molochkov
V. A. Aleshkin
T. A. Skirda
A. V. Karaulov
Yu. V. Molochkova
E. V. Antonova
author_sort V. A. Molochkov
collection DOAJ
description Background: Urogenital chlamydial infection is the most prevalent among sexually transmitted disorders that is associated with high rates of complications (chronic prostatitis, salpingoophoritis, etc.) and adverse outcomes, such as sexual and reproductive dysfunction. In the last years, the frequency of persistent antibiotic-resistant chlamydial infections has been persistently increasing that is diagnosed by immunoenzyme assay of IgG antibodies to the heat shock protein of chlamydia with a molecular weight of 60 KDa (HSP60) and by detection of secretory IgA to Chlamydia trachomatis in the semen plasma. Aim: To assess the rates of persistent chlamydial infection in patients with chronic prostatitis by measurement of serum IgG anti-HSP60 antibodies to C. trachomatis and presence of anti-chlamydial IgG in the semen plasma. Materials and methods: In a  prospective study we examined 18 patients with chronic prostatitis, aged from 21 to 58  years. The control group included 30 subjects without chlamydial urogenital disease. Clinical assessment included past history, instrumental investigations, ultrasound examination of prostate and semen vesicles. Serological tests were performed by immunoenzyme analysis in 4  test systems (“Medac”, Germany) to two antigens: a  genus-specific chlamydial lipopolysaccharide r-ELISA (anti-chlamydial IgM, IgG and IgA antibodies) and to the main outer membrain protein (МОМР) of C.  trachomatis (IgG and IgA). Anti-HSP60 antibodies were measured in the test system with HSP60-IgG-ELISA (“Medac”). The levels of secretory IgA in the seminal fluid were assessed with a  test system Chlamydia trachomatis-IgA-pELISA. Results: In 13 (72.2%) of 18 patients the chronic prostatitis was of chlamydial etiology, and in 7 (38.9%) of 18 patients there was an underlying persistent chlamydial infections with concomitant high levels of serum IgG anti-HSP60 C. trachomatis and presence of anti-chlamydial IgA antibodies in the semen plasma. In the control group, IgG anti-chlamydial antibodies were not found. Conclusion: The results obtained confirm the diagnostic value of anti-C. trachomatis IgA antibodies in identification of the etiology of inflammation in the male genital tract. They also indicate a high rate of persistent chlamydial infection in patients with chronic prostatitis and the utility of serology tests for IgG anti-HSP60 C.  trachomatis and anti-chlamydial IgA antibodies in the semen plasma.
first_indexed 2024-12-17T02:34:11Z
format Article
id doaj.art-c96feb9cf0744a1396d5a6595ab5fb2b
institution Directory Open Access Journal
issn 2072-0505
2587-9294
language Russian
last_indexed 2024-12-17T02:34:11Z
publishDate 2016-06-01
publisher MONIKI
record_format Article
series Alʹmanah Kliničeskoj Mediciny
spelling doaj.art-c96feb9cf0744a1396d5a6595ab5fb2b2022-12-21T22:06:54ZrusMONIKIAlʹmanah Kliničeskoj Mediciny2072-05052587-92942016-06-0144111412010.18786/2072-0505-2016-44-1-114-120316ON THE ASSESSMENT AND TREATMENT OF PATIENTS WITH CHRONIC PROSTATITIS IN PERSISTENT UROGENITAL CHLAMYDIOSISV. A. Molochkov0V. A. Aleshkin1T. A. Skirda2A. V. Karaulov3Yu. V. Molochkova4E. V. Antonova5Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian FederationGabrichevsky Research Institute of Epidemiology and Microbiology; 10 Admirala Makarova ul., Moscow, 125212, Russian FederationGabrichevsky Research Institute of Epidemiology and Microbiology; 10 Admirala Makarova ul., Moscow, 125212, Russian FederationI.M. Sechenov First Moscow State Medical University; 8/2 Trubetskaya ul., Moscow, 119991, Russian FederationMoscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian FederationShchelkovo Clinic for Skin and Venereal Diseases; 10 Novaya fabrika ul., Shchelkovo, Moskovskaya oblast', 141100, Russian FederationBackground: Urogenital chlamydial infection is the most prevalent among sexually transmitted disorders that is associated with high rates of complications (chronic prostatitis, salpingoophoritis, etc.) and adverse outcomes, such as sexual and reproductive dysfunction. In the last years, the frequency of persistent antibiotic-resistant chlamydial infections has been persistently increasing that is diagnosed by immunoenzyme assay of IgG antibodies to the heat shock protein of chlamydia with a molecular weight of 60 KDa (HSP60) and by detection of secretory IgA to Chlamydia trachomatis in the semen plasma. Aim: To assess the rates of persistent chlamydial infection in patients with chronic prostatitis by measurement of serum IgG anti-HSP60 antibodies to C. trachomatis and presence of anti-chlamydial IgG in the semen plasma. Materials and methods: In a  prospective study we examined 18 patients with chronic prostatitis, aged from 21 to 58  years. The control group included 30 subjects without chlamydial urogenital disease. Clinical assessment included past history, instrumental investigations, ultrasound examination of prostate and semen vesicles. Serological tests were performed by immunoenzyme analysis in 4  test systems (“Medac”, Germany) to two antigens: a  genus-specific chlamydial lipopolysaccharide r-ELISA (anti-chlamydial IgM, IgG and IgA antibodies) and to the main outer membrain protein (МОМР) of C.  trachomatis (IgG and IgA). Anti-HSP60 antibodies were measured in the test system with HSP60-IgG-ELISA (“Medac”). The levels of secretory IgA in the seminal fluid were assessed with a  test system Chlamydia trachomatis-IgA-pELISA. Results: In 13 (72.2%) of 18 patients the chronic prostatitis was of chlamydial etiology, and in 7 (38.9%) of 18 patients there was an underlying persistent chlamydial infections with concomitant high levels of serum IgG anti-HSP60 C. trachomatis and presence of anti-chlamydial IgA antibodies in the semen plasma. In the control group, IgG anti-chlamydial antibodies were not found. Conclusion: The results obtained confirm the diagnostic value of anti-C. trachomatis IgA antibodies in identification of the etiology of inflammation in the male genital tract. They also indicate a high rate of persistent chlamydial infection in patients with chronic prostatitis and the utility of serology tests for IgG anti-HSP60 C.  trachomatis and anti-chlamydial IgA antibodies in the semen plasma.https://www.almclinmed.ru/jour/article/view/316urogenital chlamydiosispersistent chlamydial infectionheat shock proteinimmunoglobulins
spellingShingle V. A. Molochkov
V. A. Aleshkin
T. A. Skirda
A. V. Karaulov
Yu. V. Molochkova
E. V. Antonova
ON THE ASSESSMENT AND TREATMENT OF PATIENTS WITH CHRONIC PROSTATITIS IN PERSISTENT UROGENITAL CHLAMYDIOSIS
Alʹmanah Kliničeskoj Mediciny
urogenital chlamydiosis
persistent chlamydial infection
heat shock protein
immunoglobulins
title ON THE ASSESSMENT AND TREATMENT OF PATIENTS WITH CHRONIC PROSTATITIS IN PERSISTENT UROGENITAL CHLAMYDIOSIS
title_full ON THE ASSESSMENT AND TREATMENT OF PATIENTS WITH CHRONIC PROSTATITIS IN PERSISTENT UROGENITAL CHLAMYDIOSIS
title_fullStr ON THE ASSESSMENT AND TREATMENT OF PATIENTS WITH CHRONIC PROSTATITIS IN PERSISTENT UROGENITAL CHLAMYDIOSIS
title_full_unstemmed ON THE ASSESSMENT AND TREATMENT OF PATIENTS WITH CHRONIC PROSTATITIS IN PERSISTENT UROGENITAL CHLAMYDIOSIS
title_short ON THE ASSESSMENT AND TREATMENT OF PATIENTS WITH CHRONIC PROSTATITIS IN PERSISTENT UROGENITAL CHLAMYDIOSIS
title_sort on the assessment and treatment of patients with chronic prostatitis in persistent urogenital chlamydiosis
topic urogenital chlamydiosis
persistent chlamydial infection
heat shock protein
immunoglobulins
url https://www.almclinmed.ru/jour/article/view/316
work_keys_str_mv AT vamolochkov ontheassessmentandtreatmentofpatientswithchronicprostatitisinpersistenturogenitalchlamydiosis
AT vaaleshkin ontheassessmentandtreatmentofpatientswithchronicprostatitisinpersistenturogenitalchlamydiosis
AT taskirda ontheassessmentandtreatmentofpatientswithchronicprostatitisinpersistenturogenitalchlamydiosis
AT avkaraulov ontheassessmentandtreatmentofpatientswithchronicprostatitisinpersistenturogenitalchlamydiosis
AT yuvmolochkova ontheassessmentandtreatmentofpatientswithchronicprostatitisinpersistenturogenitalchlamydiosis
AT evantonova ontheassessmentandtreatmentofpatientswithchronicprostatitisinpersistenturogenitalchlamydiosis